Age-related macular degeneration, the leading cause of vision loss and blindness for Americans 65 and older, is a progressive disease affecting central vision. Over time, faces, book pages and ...

The European Medicines Agency (EMA) has announced its approval of two new biosimilar medications, Afqlir and Opuviz, to treat age-related macular degeneration (ARMD). The active ingredient of both ...

Researchers have identified distinct biological features linked to a high risk of developing a severe form of age-related ...

Older diabetic patients on two GLP-1 drugs showed an increased risk of neovascular age-related macular degeneration in an observational cohort study. The absolute risk was small, however, reaching 0.2 ...

A new study from Washington University School of Medicine in St. Louis identifies a possible way to slow or block progression of age-related macular degeneration, a leading cause of blindness in ...

Share on Pinterest A commonly prescribed diabetes medication is emerging as a promising treatment for age-related macular degeneration (AMD). George Pachantouris/Getty Images Researchers say the type ...